Table 5.
Dabigatran etexilate dosing (modified from dabigatran etexilate package insert).
| Dosing | ||||
|---|---|---|---|---|
| Treatment dosing (after completion of 5 days of parenteral treatment | Age | Weight (kg) | Age (months) | Dose (mg) |
| <2 years | 3–3.9 | 3–5.9 | 30 BID | |
| 4–4.9 | 3–9.9 | 40 BID | ||
| 5–6.9 | 3–4.9 | 40 BID | ||
| 5–23.9 | 50 BID | |||
| 7–8.9 | 3–3.9 | 50 BID | ||
| 4–8.9 | 60 BID | |||
| 9–23.9 | 70 BID | |||
| 9–10.9 | 5–5.9 | 60 BID | ||
| 6–10.9 | 80 BID | |||
| 11–23.9 | 90 BID | |||
| 11–12.9 | 8–17.9 | 100 BID | ||
| 18–23.9 | 110 BID | |||
| 13–15.9 | 10–10.9 | 100 BID | ||
| 11–23.9 | 140 BID | |||
| 16–20.9 | 12–23.9 | 140 BID | ||
| 21–25.9 | 18–23.9 | 180 BID | ||
| Age | Weight (kg) | Dose (mg) | ||
| 2–11.9 years | 7–8.9 | 70 BID | ||
| 9–10.9 | 90 BID | |||
| 11–12.9 | 110 BID | |||
| 13–15.9 | 140 BID | |||
| 16–20.9 | 170 BID | |||
| 21–40.9 | 220 BID | |||
| ≥41 | 260 BID | |||
| Thromboprophylaxis dosing | Not available | |||
BID, twice a day.